Ginkgo Bioworks
BOSTON, Massachusetts, United States · Biotechnology, Manufacturing, Other
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detec
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- BOSTON, Massachusetts, United States
- Employees
- 840
- Industries
- Biotechnology, Manufacturing, Other
- Status
- Public (DNA)
- Website
- ginkgobioworks.com
- Company page
Recent activity at Ginkgo Bioworks
Employee benefit plans
Ginkgo Bioworks files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Ginkgo Bioworks: questions and answers
What does Ginkgo Bioworks do?
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detec
Where is Ginkgo Bioworks headquartered?
Ginkgo Bioworks is headquartered in BOSTON, Massachusetts, United States.
How many employees does Ginkgo Bioworks have?
Ginkgo Bioworks has about 840 employees.
What is the latest news on Ginkgo Bioworks?
On Oct 29, 2026, SEC 8-K (7.01):
Is Ginkgo Bioworks a public company?
Yes. Ginkgo Bioworks is publicly traded under the ticker DNA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy